Barclays »

Palisade Bio shares owned by Barclays

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $35k 15k 2.35
2025-03-31 $0 6 0.00

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Palisade Bio

Commodore Capital
Point72 Asset Management
Octagon Capital Advisors
Ameriprise Financial
Eversept Partners
Franklin Resources
Boxer Capital Management
Stempoint Capital
Renaissance Technologies
Vivo Capital
Vanguard Group
ADAR1 Capital Management
Artia Global Partners
BlackRock
OrbiMed Advisors

View all funds holding Palisade Bio